Discovery of an orally active VHL-recruiting PROTAC that achieves robust HMGCR degradation and potent hypolipidemic activity in vivo
Guoshun Luo(China Pharmaceutical University), Hua Xiang(Southwest Minzu University), Lizhe Zhu(Chinese University of Hong Kong, Shenzhen), Xin Lin(Central South University), Maoxu Xiao(China Pharmaceutical University), Hanlin Wei(Hunan University), Yu Chen(University of Wisconsin System), Xinyu Li(Shandong University), Kun Xi(Chinese University of Hong Kong, Shenzhen), Zhenbang Li(China Pharmaceutical University)
Cited by 77
Related Papers
miRTarBase update 2022: an informative resource for experimentally validated miRNA–target interactions
|Nucleic Acids Research|2021|1k
Regulatory mechanisms of PD-1/PD-L1 in cancers
|Molecular Cancer|2024|619
Ferritin Nanocages To Encapsulate and Deliver Photosensitizers for Efficient Photodynamic Therapy against Cancer
|ACS Nano|2013|270
Chimeric Ferritin Nanocages for Multiple Function Loading and Multimodal Imaging
|Nano Letters|2011|263